Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Accenture
Deloitte
Colorcon
UBS
Daiichi Sankyo
US Department of Justice
Fish and Richardson
Fuji

Generated: April 20, 2018

DrugPatentWatch Database Preview

ISOPAQUE 440 Drug Profile

« Back to Dashboard

Which patents cover Isopaque 440, and when can generic versions of Isopaque 440 launch?

Isopaque 440 is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in ISOPAQUE 440 is calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium. There are two hundred and seventy-five drug master file entries for this compound. Additional details are available on the calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium profile page.
Summary for ISOPAQUE 440
Drug patent expirations by year for ISOPAQUE 440

US Patents and Regulatory Information for ISOPAQUE 440

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare ISOPAQUE 440 calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium INJECTABLE;INJECTION 016847-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Citi
Covington
Baxter
Accenture
Harvard Business School
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.